Table 2
Enrolment and outcome measurements in DigiYoga Care
| Enrolment | Allocation | Postallocation | |||||
| TIMEPOINT** | -t1 | 0 | t1 3 mon | t2 6 Mon | t3 12 Mon | t4 24 Mon | |
| Eligibility screen | x | ||||||
| Informed consent | x | ||||||
| Randomisation | x | ||||||
| Yoga intervention |  x | x | |||||
| ASSESSMENTS: | |||||||
| Blood samples | Proinflammatory and metabolic markers | x | x | x | |||
| Fatigue | MFI | x | x | x | x | x | |
| Health economic evaluation | EuroQol-5 (EQ-5D-5L) | x | x | x | x | x | |
| Health-related quality of life | EORTC-QLQ30 –BR23 | x | x | x | x | x | |
| Stress | PSS | x | x | x | x | x | |
| Physical activity | Accelerometer | x | x | x | x | ||
| General measurements | Body length, weight and heart rate | x | x | ||||
| Medical and clinical background data | Treatment, dose intensity, toxicity, comorbidity, disease recurrence, death, sick days and return to work | x | |||||
MFI, Multidimensional Fatigue Inventory; PSS, Perceived Stress Scale.